Automation system for the pharmaceutical industry scale-X™ nitro

for vaccine development

Automation system for flexible, low-footprint and cost-effective viral manufacturing Engineered to scale bioprocessing operations into commercial manufacturing, the scale-X™ nitro controller delivers flexible, low-footprint, and cost-effective automation for vaccine and viral vectors production. Integrating 200m² and 600m² scale-X nitro bioreactors, the new controller, as part of the scale-X platform, enables high productivity. With its compact and optimized design, the scale-X nitro controller allows for rapid deployment in diverse environments while maintaining maximum operational flexibility. It delivers precision automation, ensuring high performance, reliability, and productivity for commercial-scale biomanufacturing. Fast-track your set-up With a compact footprint of just 1.6m² and a height under 2 meters, the scale-X nitro controller is delivered as a single, wheeled unit, enabling rapid set-up and seamless integration into any biomanufacturing environment, minimizing downtime and accelerating production. Simplify your operations Designed with the end user in mind, the controller features an intuitive interface and flexible, easy-to-install multi-use flow paths. This design simplifies operation, reduces the learning curve, and enables non-specialized operators to manage the system effectively, thereby decreasing running costs. Slash production expenses By integrating the scale-X nitro controller, manufacturers can realize significant Cost of Goods Sold (COGS)’ savings — ranging from 36% to 82% compared to traditional methods1.